SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) today reported further highlights from more than 200 abstracts summarizing presentations at the International Congress on Hyperthermic Oncology (ICHO) conducted this month in Munich, Germany. This conference is the combined meeting of the European Society for Hyperthermic Oncology (ESHO), the U.S. Society of Thermal Medicine (STM) and the Asian Society for Hyperthermic Oncology (ASHO). Over the last years, the field of clinical hyperthermia has become increasingly dynamic. Recent results of randomized phase II and III studies as well as ongoing basic research activities have established hyperthermia as a treatment option in conjunction with standard regimens in the field of oncology.
